Diabetes, Vol 49, Issue 3 392-398, Copyright © 2000 by American Diabetes Association

ARTICLES

Quantitative and functional characterization of muscarinic receptor subtypes in insulin-secreting cell lines and rat pancreatic islets

TP Iismaa, EA Kerr, JR Wilson, L Carpenter, N Sims and TJ Biden
Garvan Institute of Medical Research, St. Vincent's Hospital, Sydney, Australia.

Expression of muscarinic receptors in rat islets, RINm5F cells, and INS-1 cells was established by reverse transcriptase-polymerase chain reaction (RT-PCR) and quantified by RNase protection. Both methods indicated that m3 and m1 receptors were expressed approximately equally in the various cellular preparations and to a much greater extent than the m5 subtype. However, the cell lines, especially RINm5F cells, expressed less of a given receptor subtype than did islets. Immunohistochemistry indicated that m3 receptors were expressed throughout the islet core. Binding studies using the radiolabeled muscarinic receptor antagonist QNB demonstrated a maximal binding capacity of INS-1 cells of 23.0+/-2.9 fmol/mg protein. Functional analyses were undertaken using INS-1 cells stably transfected with either m1 or m3 receptor cDNAs. Overexpression of either receptor did not affect basal responses but markedly enhanced maximal responses to the muscarinic receptor agonist carbachol. Although maximal hydrolysis of phosphatidylinositol 4,5-bisphosphate (Ptd InsP2) was twofold greater in m1-transfectants as compared with m3-transfectants, cell lines overexpressing either receptor gave essentially equivalent secretory responses to a full range of carbachol doses. The results demonstrate that both m1 and m3 muscarinic receptors are well expressed in pancreatic beta-cells, functionally linked to signaling pathways, and capable of initiating insulin secretion with equal potencies.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. Mitrani, M. Srinivasan, C. Dodds, and M. S. Patel Autonomic involvement in the permanent metabolic programming of hyperinsulinemia in the high-carbohydrate rat model Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1364 - E1377. [Abstract] [Full Text] [PDF]

				P. Mitrani, M. Srinivasan, C. Dodds, and M. S. Patel Role of the autonomic nervous system in the development of hyperinsulinemia by high-carbohydrate formula feeding to neonatal rats Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1069 - E1078. [Abstract] [Full Text] [PDF]

				Y. Guo, M. Traurig, L. Ma, S. Kobes, I. Harper, A. M. Infante, C. Bogardus, L. J. Baier, and M. Prochazka CHRM3 Gene Variation Is Associated With Decreased Acute Insulin Secretion and Increased Risk for Early-Onset Type 2 Diabetes in Pima Indians Diabetes, December 1, 2006; 55(12): 3625 - 3629. [Abstract] [Full Text] [PDF]

				S. G. Laychock, S. M. Sessanna, M.-H. Lin, and L. D. Mastrandrea Sphingosine 1-Phosphate Affects Cytokine-Induced Apoptosis in Rat Pancreatic Islet {beta}-Cells Endocrinology, October 1, 2006; 147(10): 4705 - 4712. [Abstract] [Full Text] [PDF]

				M. Ohtani, T. Oka, M. Badyuk, Y. Xiao, K. J. Kellar, and J. W. Daly Mouse beta-TC6 Insulinoma Cells: High Expression of Functional {alpha}3beta4 Nicotinic Receptors Mediating Membrane Potential, Intracellular Calcium, and Insulin Release Mol. Pharmacol., March 1, 2006; 69(3): 899 - 907. [Abstract] [Full Text] [PDF]

				C.-W. Lin, F. Yan, S. Shimamura, S. Barg, and S.-L. Shyng Membrane Phosphoinositides Control Insulin Secretion Through Their Effects on ATP-Sensitive K+ Channel Activity Diabetes, October 1, 2005; 54(10): 2852 - 2858. [Abstract] [Full Text] [PDF]

				W. Hirdes, L. F. Horowitz, and B. Hille Muscarinic modulation of erg potassium current J. Physiol., August 15, 2004; 559(1): 67 - 84. [Abstract] [Full Text] [PDF]

				A. Duttaroy, C. L. Zimliki, D. Gautam, Y. Cui, D. Mears, and J. Wess Muscarinic Stimulation of Pancreatic Insulin and Glucagon Release Is Abolished in M3 Muscarinic Acetylcholine Receptor-Deficient Mice Diabetes, July 1, 2004; 53(7): 1714 - 1720. [Abstract] [Full Text] [PDF]

				M. E. Doyle and J. M. Egan Pharmacological Agents That Directly Modulate Insulin Secretion Pharmacol. Rev., March 1, 2003; 55(1): 105 - 131. [Abstract] [Full Text] [PDF]

				P. Gilon and J.-C. Henquin Mechanisms and Physiological Significance of the Cholinergic Control of Pancreatic {beta}-Cell Function Endocr. Rev., October 1, 2001; 22(5): 565 - 604. [Abstract] [Full Text] [PDF]

				B. Lee, W. Gai, and S. G. Laychock Proteasomal Activation Mediates Down-Regulation of Inositol 1,4,5-Trisphosphate Receptor and Calcium Mobilization in Rat Pancreatic Islets Endocrinology, May 1, 2001; 142(5): 1744 - 1751. [Abstract] [Full Text]

				C. J. Mitchell, M. M. Kelly, M. Blewitt, J. R. Wilson, and T. J. Biden Phospholipase C-gamma Mediates the Hydrolysis of Phosphatidylinositol, but Not of Phosphatidylinositol 4,5-Bisphoshate, in Carbamylcholine-stimulated Islets of Langerhans J. Biol. Chem., May 25, 2001; 276(22): 19072 - 19077. [Abstract] [Full Text] [PDF]